Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24-month results from the DERBY and OAKS phase 3 trials (RS 2022) - Apellis Medical Hub Canada

Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24-month results from the DERBY and OAKS phase 3 trials

Share Via Email

Back to Conference Resources

GA Congress Presentations Retina Society 2022

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.